JP2002503724A5 - - Google Patents

Download PDF

Info

Publication number
JP2002503724A5
JP2002503724A5 JP2000532400A JP2000532400A JP2002503724A5 JP 2002503724 A5 JP2002503724 A5 JP 2002503724A5 JP 2000532400 A JP2000532400 A JP 2000532400A JP 2000532400 A JP2000532400 A JP 2000532400A JP 2002503724 A5 JP2002503724 A5 JP 2002503724A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
hydrogen
substituents
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000532400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002503724A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/003608 external-priority patent/WO1999042448A1/en
Publication of JP2002503724A publication Critical patent/JP2002503724A/ja
Publication of JP2002503724A5 publication Critical patent/JP2002503724A5/ja
Pending legal-status Critical Current

Links

JP2000532400A 1998-02-20 1999-02-19 良性前立腺過形成の治療で用いるに有用な新規な置換ピリジノアリールピペラジン類 Pending JP2002503724A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20
US60/075,321 1998-02-20
PCT/US1999/003608 WO1999042448A1 (en) 1998-02-20 1999-02-19 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia

Publications (2)

Publication Number Publication Date
JP2002503724A JP2002503724A (ja) 2002-02-05
JP2002503724A5 true JP2002503724A5 (enExample) 2006-03-30

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000532400A Pending JP2002503724A (ja) 1998-02-20 1999-02-19 良性前立腺過形成の治療で用いるに有用な新規な置換ピリジノアリールピペラジン類

Country Status (23)

Country Link
US (1) US6218396B1 (enExample)
EP (1) EP1054868B1 (enExample)
JP (1) JP2002503724A (enExample)
KR (1) KR100591028B1 (enExample)
CN (1) CN1121390C (enExample)
AR (1) AR014626A1 (enExample)
AT (1) ATE250580T1 (enExample)
AU (1) AU766398B2 (enExample)
BR (1) BR9909647A (enExample)
CZ (1) CZ294136B6 (enExample)
DE (1) DE69911582T2 (enExample)
DK (1) DK1054868T3 (enExample)
ES (1) ES2209468T3 (enExample)
HU (1) HUP0100781A3 (enExample)
IL (2) IL137954A0 (enExample)
NO (1) NO317103B1 (enExample)
NZ (1) NZ506462A (enExample)
PL (1) PL342339A1 (enExample)
PT (1) PT1054868E (enExample)
TR (1) TR200003220T2 (enExample)
TW (1) TW565555B (enExample)
WO (1) WO1999042448A1 (enExample)
ZA (1) ZA991315B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269807C (zh) * 1997-05-12 2006-08-16 奥索-麦克尼尔药品公司 可用于治疗良性前列腺肥大的芳基取代哌嗪
ES2282279T3 (es) 2000-08-08 2007-10-16 Ortho-Mcneil Pharmaceutical, Inc. No-imidazol ariloxipiperidina como ligandos del receptor h3.
JP3878178B2 (ja) * 2001-12-28 2007-02-07 武田薬品工業株式会社 排尿障害予防治療剤
USD545208S1 (en) 2006-09-27 2007-06-26 001 Corporation Perfume bottle and cap
EP2077262A4 (en) * 2006-10-23 2011-12-28 Takeda Pharmaceutical IMINOPYRIDINE DERIVATIVE AND USE THEREOF
MX2010011652A (es) * 2008-04-23 2010-12-06 Takeda Pharmaceutical Derivados de iminopiridina y uso de los mismos.
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives

Similar Documents

Publication Publication Date Title
RU2225389C2 (ru) Производные аминометилкарбоновой кислоты и фармацевтическая композиция на их основе
RU2317294C2 (ru) (имидазол-1-илметил)пиридазин в качестве блокатора nmda рецептора
JP2001526218A5 (enExample)
JP2003500442A5 (enExample)
JP2003509349A5 (enExample)
JP2004501930A5 (enExample)
JP2005523922A5 (enExample)
JP2003503449A5 (enExample)
JP2002030084A5 (enExample)
JP2002503724A5 (enExample)
JP2005511698A5 (enExample)
BR0207872A (pt) Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração
SE0201659D0 (sv) Modified release pharmaceutical formulation
CA2281426A1 (en) Substituted indole compounds as anti-inflammatory and analgesic agents
JP2002527414A5 (enExample)
CA2332087A1 (en) Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
EA200501703A1 (ru) Применение производных азетидинкарбоксамида в терапии
JP2000159790A5 (enExample)
JP2002506864A5 (enExample)
JP2004525178A5 (enExample)
JP2002529497A5 (enExample)
JPH1036365A5 (enExample)
CA2292921A1 (en) Aryl carboxylic acid and tetrazole derivatives
JP2001519413A5 (enExample)
JP2007507472A5 (enExample)